MAPT and amyloidosis: With regards to AD research, many radiotracers targeting amyloidosis and tau aggregates have already been well-established, contributing to a more detailed understanding of the temporal and spatial dynamics of the disease’s pathomechanisms (Villemagne et al., 2018).